Small-molecule factor D inhibitors targeting the alternative complement pathway

被引：0

作者：

Jürgen Maibaum

Sha-Mei Liao

Anna Vulpetti

Nils Ostermann

Stefan Randl

Simon Rüdisser

Edwige Lorthiois

Paul Erbel

Bernd Kinzel

Fabrice A Kolb

Samuel Barbieri

Julia Wagner

Corinne Durand

Kamal Fettis

Solene Dussauge

Nicola Hughes

Omar Delgado

Ulrich Hommel

Ty Gould

Aengus Mac Sweeney

Bernd Gerhartz

Frederic Cumin

Stefanie Flohr

Anna Schubart

Bruce Jaffee

Richard Harrison

Antonio Maria Risitano

Jörg Eder

Karen Anderson

机构：

[1] Novartis Institutes for BioMedical Research,Drug Discovery Department

[2] Novartis Pharma AG,Department of Clinical Medicine and Surgery, Division of Hematology

[3] Novartis Campus,undefined

[4] Novartis Institutes for BioMedical Research,undefined

[5] Evonik Japan Co.,undefined

[6] Shinjuku-ku,undefined

[7] Pharma Research and Early Development,undefined

[8] Roche Innovation Center Basel,undefined

[9] Actelion Pharmaceuticals Ltd.,undefined

[10] Institute of Infection and Immunity,undefined

[11] School of Medicine,undefined

[12] Cardiff University,undefined

[13] Henry Wellcome Building,undefined

[14] Heath Park,undefined

[15] University of Naples,undefined

来源：

Nature Chemical Biology | 2016年 / 12卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A fragment-based design approach identifies reversible inhibitors targeting human protease complement factor D (FD), which is required for amplification of complement C3 signaling. FD inhibitors act as systemic regulators of complement activation in vivo.[graphic not available: see fulltext]

引用

页码：1105 / 1110

页数：5

共 50 条

[1] Small-molecule factor D inhibitors targeting the alternative complement pathway
Maibaum, Jurgen
Liao, Sha-Mei
Vulpetti, Anna
Ostermann, Nils
Randl, Stefan
Rudisser, Simon
Lorthiois, Edwige
Erbel, Paul
Kinzel, Bernd
Kolb, Fabrice A.
Barbieri, Samuel
Wagner, Julia
Durand, Corinne
Fettis, Kamal
Dussauge, Solene
Hughes, Nicola
Delgado, Omar
Hommel, Ulrich
Gould, Ty
Mac Sweeney, Aengus
Gerhartz, Bernd
Cumin, Frederic
Flohr, Stefanie
Schubart, Anna
Jaffee, Bruce
Harrison, Richard
Risitano, Antonio Maria
Eder, Jorg
Anderson, Karen
NATURE CHEMICAL BIOLOGY, 2016, 12 (12) : 1105 - +
[2] Novel Small-Molecule Inhibitors Targeting Complement Factor D for Therapy of Paroxysmal Nocturnal Hemoglobinuria
Morgan, B. Paul
Thanassi, Jane
Podos, Steven
Phadke, Avinash
Gadhachanda, Venkat
Pais, Godwin
Hashimoto, Akihiro
Wang, Qiuping
Chen, Dawei
Wang, Xiangzhu
Agarwal, Atul
Deshpande, Milind
Huang, Yongqing
Wiles, Jason
Huang, Mingjun
BLOOD, 2014, 124 (21)
[3] Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo
Lorthiois, Edwige
Anderson, Karen
Vulpetti, Anna
Rogel, Olivier
Cumin, Frederic
Ostermann, Nils
Steinbacher, Stefan
Mac Sweeney, Aengus
Delgado, Omar
Liao, Sha-Mei
Randl, Stefan
Rudisser, Simon
Dussauge, Solene
Fettis, Kamal
Kieffer, Laurence
de Erkenez, Andrea
Yang, Louis
Hartwieg, Constanze
Argikar, Upendra A.
La Bonte, Laura R.
Newton, Ronald
Kansara, Viral
Flohr, Stefanie
Hommel, Ulrich
Jaffee, Bruce
Maibaum, Jurgen
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5717 - 5735
[4] Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Yuan, Xuan
Gavriilaki, Eleni
Thanassi, Jane A.
Yang, Guangwei
Baines, Andrea C.
Podos, Steven D.
Huang, Yongqing
Huang, Mingjun
Brodsky, Robert A.
HAEMATOLOGICA, 2017, 102 (03) : 466 - 475
[5] Targeting the transcription factor Myb by small-molecule inhibitors
Uttarkar, Sagar
Frarnpton, Jon
Klempnauer, Karl-Heinz
EXPERIMENTAL HEMATOLOGY, 2017, 47 : 31 - 35
[6] Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors
McCubrey, James A.
Milella, Michele
Tafuri, Agostino
Martelli, Alberto M.
Lunghi, Paolo
Bonati, Antonio
Cervello, Melchiorre
Lee, John T.
Steelman, Linda S.
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (06) : 614 - 630
[7] Structure-based design of highly potent and selective small-molecule reversible factor D inhibitors blocking in vivo alternative complement pathway activation
Maibaum, Juergen
Anderson, Karen
Vulpetti, Anna
Lorthiois, Edwige
Ostermann, Nils
Liao, Sha-Mei
Randl, Stefan
Rogel, Olivier
Paul, Erbel
Gerhartz, Bernd
Argikar, Upendra
Muller, Irene
Hommel, Ulrich
Kinzel, Bernd
Kolb, Fabrice
Rudisser, Simon
Cumin, Frederic
Sedrani, Richard
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[8] Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway
Karki, Rajeshri G.
Powers, James
Mainolfi, Nello
Anderson, Karen
Belanger, David B.
Liu, Donglei
Ji, Nan
Jendza, Keith
Gelin, Christine F.
Mac Sweeney, Aengus
Solovay, Catherine
Delgado, Omar
Crowley, Maura
Liao, Sha-Mei
Argikar, Upendra A.
Flohr, Stefanie
La Bonte, Laura R.
Lorthiois, Edwige L.
Vulpetti, Anna
Brown, Ann
Long, Debby
Prentiss, Melissa
Gradoux, Nathalie
de Erkenez, Andrea
Cumin, Frederic
Adams, Christopher
Jaffee, Bruce
Mogi, Muneto
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4656 - 4668
[9] Targeting the Dimerization of Epidermal Growth Factor Receptors with Small-Molecule Inhibitors
Yang, Robert Y. C.
Yang, Katherine S.
Pike, Linda J.
Marshall, Garland R.
CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 76 (01) : 1 - 9
[10] Small-Molecule Inhibitors of the Pseudaminic Acid Biosynthetic Pathway: Targeting Motility as a Key Bacterial Virulence Factor
Menard, Robert
Schoenhofen, Ian C.
Tao, Limei
Aubry, Annie
Bouchard, Patrice
Reid, Christopher W.
Lachance, Paule
Twine, Susan M.
Fulton, Kelly M.
Cui, Qizhi
Hogues, Herve
Purisima, Enrico O.
Sulea, Traian
Logan, Susan M.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7430 - 7440

← 1 2 3 4 5 →